← Leaderboards
Robert A Britton
Baylor College Of Medicine
$17,520,348
Attributed
$29,914,258
Total exposure
19
Grants
13
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $6.4M · FY2010–25$10M$7.5M$5M$2.5M$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$42,341,001 · 20
By mechanism
U19$20,420,501 · 8
U01$7,916,381 · 1
R01$7,776,924 · 4
U24$3,357,381 · 1
R21$1,448,330 · 4
R33$1,401,868 · 1
Top collaborators
- Laura R Mccabe8 shared
- Katherine Paige Lemon6 shared
- Anthony W Maresso6 shared
- Narayanan Parameswaran6 shared
- Kevin W Garey5 shared
- Katy Patras5 shared
- Tor C. Savidge5 shared
- Joe Sorg5 shared
Most similar at Baylor College Of Medicine
Same institution · by research overlap
- Christine Beeton$7,582,844
- Kjersti Marie Aagaard-Tillery$19,552,738
- Stephen Carl Pflugfelder$11,614,037
- Cintia Sade De Paiva$7,590,072
- Kristi Louise Hoffman$671,476
Others in their field
Top investigators on “Communities”
- Eric S Lander · Whitehead Institute For Biomedical Res$547,749,172
- David Heimbrook · Leidos Biomedical Research, Inc.$526,770,200
- Larry Arthur$517,751,165
- Lawrence Corey · Fred Hutchinson Cancer Center$484,622,485
- David R. Weir · University Of Michigan At Ann Arbor$394,331,036
- Albert Lazzarini · California Institute Of Technology$381,143,533
Research focus
CommunitiesIntestinesMicrobial CommunityMicrobialBacteriaMicrobiomeAntibiotic ResistancePathogenClostridium DifficileGenesInfectionMicrobiotaAntibioticsPreventCombatMouse ModelPropertyInnovationBaseMucous MembraneComplexBacteriophagesGeneticSurface
Grant awards (62)
Microbiome Discovery and Mechanisms to Combat Antibiotic Resistance at Mucosal Surfaces$2,479,201
U19 · FY2025 · AI · contact PI
Multi-method investigation and characterization of the ocular microbiome$1,493,152
U24 · FY2025 · EY
Engineered probiotic for the treatment of autoimmune diseases$692,859
R01 · FY2025 · AI
Defined microbial communities to prevent and eradicate infection by AMR pathogens$670,879
U19 · FY2025 · AI · contact PI
Microbial and Phage Cultivation Core$397,049
U19 · FY2025 · AI · contact PI
Admin Core - Britton$344,994
U19 · FY2025 · AI · contact PI
Investigating the role of intestinal-derived oxytocin in social behavior and gut inflammation.$200,000
R21 · FY2025 · HD · contact PI
Engineered Microbes to Mitigate Intestinal Radiation Damage$160,125
R21 · FY2025 · AI
Microbiome Discovery and Mechanisms to Combat Antibiotic Resistance at Mucosal Surfaces$2,497,111
U19 · FY2024 · AI · contact PI
Multi-method investigation and characterization of the ocular microbiome$1,200,972
U24 · FY2024 · EY
Engineered probiotic for the treatment of autoimmune diseases$675,152
R01 · FY2024 · AI
Defined microbial communities to prevent and eradicate infection by AMR pathogens$535,780
U19 · FY2024 · AI · contact PI
Microbial and Phage Cultivation Core$257,963
U19 · FY2024 · AI · contact PI
Investigating the role of intestinal-derived oxytocin in social behavior and gut inflammation.$240,000
R21 · FY2024 · HD · contact PI
Admin Core - Britton$235,119
U19 · FY2024 · AI · contact PI
Microbiome Discovery and Mechanisms to Combat Antibiotic Resistance at Mucosal Surfaces$119,807
U19 · FY2024 · AI · contact PI
Microbiome Discovery and Mechanisms to Combat Antibiotic Resistance at Mucosal Surfaces$2,537,842
U19 · FY2023 · AI · contact PI
Engineered probiotic for the treatment of autoimmune diseases$682,280
R01 · FY2023 · AI
Multi-method investigation and characterization of the ocular microbiome$663,257
U24 · FY2023 · EY
Defined microbial communities to prevent and eradicate infection by AMR pathogens$568,690
U19 · FY2023 · AI · contact PI
Microbial and Phage Cultivation Core$382,374
U19 · FY2023 · AI · contact PI
Admin Core - Britton$240,242
U19 · FY2023 · AI · contact PI
Microbiome Discovery and Mechanisms to Combat Antibiotic Resistance at Mucosal Surfaces$2,402,665
U19 · FY2022 · AI · contact PI
Admin Core - Britton$400,445
U19 · FY2022 · AI · contact PI
Defined microbial communities to prevent and eradicate infection by AMR pathogens$400,444
U19 · FY2022 · AI · contact PI
Microbial and Phage Cultivation Core$400,444
U19 · FY2022 · AI · contact PI
Diet driven evolution of epidemic ribotypes of Clostridium difficile$396,250
R01 · FY2022 · AI · contact PI
Microbiome Discovery and Mechanisms to Combat Antibiotic Resistance at Mucosal Surfaces$2,390,117
U19 · FY2021 · AI · contact PI
Defined microbial communities to prevent and eradicate infection by AMR pathogens$533,331
U19 · FY2021 · AI · contact PI
Diet driven evolution of epidemic ribotypes of Clostridium difficile$396,250
R01 · FY2021 · AI · contact PI
Microbial and Phage Cultivation Core$339,531
U19 · FY2021 · AI · contact PI
Admin Core - Britton$212,023
U19 · FY2021 · AI · contact PI
Decoding Antibiotic-induced Susceptibility to Clostridium difficile Infection$1,486,851
U01 · FY2020 · AI
Defined microbial communities for the treatment of recurrent C. difficile infection$461,232
R33 · FY2020 · AI · contact PI
Diet driven evolution of epidemic ribotypes of Clostridium difficile$396,250
R01 · FY2020 · AI · contact PI
Decoding Antibiotic-induced Susceptibility to Clostridium difficile Infection$1,482,023
U01 · FY2019 · AI
Defined microbial communities for the treatment of recurrent C. difficile infection$475,500
R33 · FY2019 · AI · contact PI
Diet driven evolution of epidemic ribotypes of Clostridium difficile$396,250
R01 · FY2019 · AI · contact PI
Decoding Antibiotic-induced Susceptibility to Clostridium difficile Infection$1,952,767
U01 · FY2018 · AI
Defined microbial communities for the treatment of recurrent C. difficile infection$465,136
R33 · FY2018 · AI · contact PI
Diet driven evolution of epidemic ribotypes of Clostridium difficile$389,230
R01 · FY2018 · AI · contact PI
GTPase control of large ribosome subunit biogenesis$375,162
R01 · FY2018 · GM · contact PI
Decoding Antibiotic-induced Susceptibility to Clostridium difficile Infection$1,494,740
U01 · FY2017 · AI
Mechanistic basis of probiotic prevention of osteoporosis$397,146
R01 · FY2017 · AT
GTPase control of large ribosome subunit biogenesis$377,412
R01 · FY2017 · GM · contact PI
Defined microbial communities for the treatment of recurrent C. difficile infection$194,278
R21 · FY2017 · AI · contact PI
Decoding Antibiotic-induced Susceptibility to Clostridium difficile Infection$1,500,000
U01 · FY2016 · AI
Mechanistic basis of probiotic prevention of osteoporosis$409,354
R01 · FY2016 · AT
GTPase control of large ribosome subunit biogenesis$379,596
R01 · FY2016 · GM · contact PI
Defined microbial communities for the treatment of recurrent C. difficile infection$237,827
R21 · FY2016 · AI · contact PI
Mechanistic basis of probiotic prevention of osteoporosis$153,487
R01 · FY2016 · AT
GTPase control of large ribosome subunit biogenesis$410,374
R01 · FY2015 · GM · contact PI
Mechanistic basis of probiotic prevention of osteoporosis$398,628
R01 · FY2015 · AT
Mechanistic basis of probiotic prevention of osteoporosis$414,114
R01 · FY2014 · AT
Elucidating the Role of the Intestinal Microbiota in Pathogen Resistance$632,169
U19 · FY2013 · AI · contact PI
Mechanistic basis of probiotic prevention of osteoporosis$437,130
R01 · FY2013 · AT · contact PI
Elucidating the Role of the Intestinal Microbiota in Pathogen Resistance$568,632
U19 · FY2012 · AI · contact PI
Elucidating the Role of the Intestinal Microbiota in Pathogen Resistance$431,838
U19 · FY2011 · AI · contact PI
Probiotics and Bone Health - Role of Gender and Intestinal Health$188,100
R21 · FY2011 · AT
Elucidating the Role of the Intestinal Microbiota in Pathogen Resistance$441,811
U19 · FY2010 · AI · contact PI
Probiotics and Bone Health - Role of Gender and Intestinal Health$228,000
R21 · FY2010 · AT
CHROMOSOME PARTITIONING IN BACILLUS SUBTILUS$19,616
F32 · FY2000 · GM